Thermo Fisher Scientific (TMO) Accumulated Expenses (2009 - 2026)

Thermo Fisher Scientific has reported Accumulated Expenses for 18 years, with the latest figure at $1.7 billion in Q2 2026.

• Accumulated Expenses for Q2 2026 came in at $1.7 billion, up 11.59% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 11.59% YoY), and the FY2025 annual result was $2.0 billion, changed 0.35% from the prior year.
• Accumulated Expenses rose to $1.7 billion in Q2 2026, from $1.6 billion in the prior quarter.
• Over five years, Accumulated Expenses peaked at $2.1 billion in Q4 2022 and troughed at $1.3 billion in Q2 2023.
• A 5-year average of $1.6 billion and a median of $1.6 billion in 2022 frame the typical range for Accumulated Expenses.
• The widest annual swing landed in 2023, when Accumulated Expenses dropped 23.93%; it then advanced 24.86% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $2.1 billion in 2022, then retreated by 23.82% to $1.6 billion in 2023, then advanced by 24.56% to $2.0 billion in 2024, then climbed by 0.35% to $2.0 billion in 2025, then fell by 15.09% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $1.7 billion in Q2 2026, $1.6 billion in Q1 2026, and $2.0 billion in Q4 2025.